At the 21st CIMT Annual Meeting Rafet Rafet Basar MD Anderson Cancer Center will present methods to enhance the potency of NK cellular therapy products using state of the art genetic engineering strategies. To register for #CIMT2024 , go to meeting.cimt.eu

New insights into overcoming immune deserts in tumors  TRON Mainz  BioNTech SE. Read our digest here 👉 bit.ly/43t3LDl

BioNTech has always been deeply rooted in academia. #STEM grads can now explore #science projects and apply for a full-time contract via our ATLAS #PhD program, a collab with TRON. Students with a sweet spot for #biomedical #research can apply by Oct 31. atlas-phdprogram.com/how-to-apply

Early-career cancer immunologists: Learn and connect with peers and scientific leaders in an extraordinary retreat setting in the Austrian Alps, January 25-28, 2024. Apply by October 23, 2023.
cimt.eu/winter-school

CIMT crew Mustafa Diken, Christine Castle and Jan Beck having a great time @ #CICON23 . Excellent science & great pizza. #cancerimmunotherapy in #milan

Submit your abstract and get ready for #CICON23 in Milan. cancerimmunotherapyconference.org AACR Cancer Research Institute ENCI

Before we are exploring the vineyards around Illasi, Markus Maeurer presents #immunosurgery at ChampalimaudF which fuses research development and new treatments for patients with cancer Cancer Immunotherapy Summer School

| #TRONpublications |
We are proud to have contributed to the discovery that ZNF827 is strongly induced during EMT transition and modulates #splicing in brain development and #breastcancer metastasis. Now published in Nature Cell Biology 👉 doi.org/10.1038/s41556…
#epigenetics

Great ideas are our starting point to target further challenges 🚀
We proudly present our new #website created in close collaboration with labor.digital

Take a look and explore our new site! ▶️ tron-mainz.de

#TRONMainz #website

Great science and conversations at the CIMT Poster Exhibit #CIMT2022 . 193 abstracts are being presented on-site at the Rheingoldhalle congress center.

📸 Our constructively discussing group of #researchers needs a coffee break ☕️ to strengthen for further fruitful exchange at the #Yscript kick-off meeting at the beautiful Centre International Hotel Dupanloup of Université d'Orléans. #mRNA #biotech European Innovation Council

We are looking for an excellent researcher as a Junior Group Leader (m/f/d) of a Research Group on “Modulating #inflammation in #cardiovascular disease”.
Project benefits include a start-up package and a full five year funding of the research group.
tron-mainz.de/wp-content/upl…

Sharing results from preclinical studies on the targeting of myeloid derived suppressor cells in #cancer , Dmitry Gabrilovich will speak at #CIMT2022 .
Gabrilovich Lab #cancer immunotherapy

Chiara Bonini Ospedale San Raffaele shares her expertise on #genome editing for cancer #immmunotherapy . We're excited to hear her talk at #CIMT2022 in Mainz, Germany. meeting.cimt.eu

Joining CIMT from Johns Hopkins Medicine Kellie Smith Kellie N. Smith will talk about mechanisms of response and resistance to checkpoint blockade using integrated #immunogenomics .
meeting.cimt.eu

Mustafa Diken was interviewed by WZ | Wiener Zeitung on the development of #mRNA #cancer #vaccines . Mustafa talked about the research at TRON and the potential the technology offers, but also about hurdles encountered in developing a therapeutic vaccine. wienerzeitung.at/nachrichten/wi…

Check out our new publication on #EasyFuse , #TRON ´s computational pipeline to detect individual and #cancer -specific #fusion genes in Nature Biotechnology rdcu.be/cKEg3

TRON is excited that EU has selected the #Yscript Consortium for #funding ! Together with Pichon Chantal, CNRS 🌍 and other partners, TRON aims to establish a #mRNA #bioproduction process in #yeast . Yscript European Innovation Council For more info, see yscript.eu

📢Excited to kick off activities for #Yscript project today – aiming at establishing a specific #mRNA #bioproduction process in yeast in order to develop novel therapeutics for many diseases. 🇫🇷Coordinated by Pichon Chantal, CNRS 🌍. 🇪🇺Funded by European Innovation Council. 👉yscript.eu.

New phase I/II trial data of CLDN6 CAR-T and CARVac-based in vivo expansion to treat patients with CLDN6+ advanced solid tumors. Andreas Mackensen Uniklinikum Erlangen will present. Meet him and other speakers at #CIMT2022 #cancerimmunotherapy meeting.cimt.eu